About Actuate Therapeutics
Actuate Therapeutics is a private company based in Fort Worth, Texas. It has reported $72,790,625 raised in nine offerings on Form D since October 2015. Its chief executive is Daniel Schmitt.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 2024 | Mar 6, 2024 | $3,000,000of $5.0M target | 1 | $3.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 30, 2022 | Oct 19, 2022amended Dec 15, 2022 | $19,336,491of $50.0M target | 95 | $203K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 30, 2020 | Dec 10, 2020 | $14,482,301of $50.0M target | 14 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Oct 1, 2019 | Oct 15, 2019amended Nov 14, 2019 | $6,500,000fully sold | 17 | $382K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 30, 2019 | May 13, 2019 | $21,886,833of $23.9M target | 21 | $1.0M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 28, 2018 | Sep 12, 2018 | $4,025,000fully sold | 18 | $223K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 17, 2017 | Mar 20, 2017 | $3,000,000of $5.0M target | 2 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Jan 18, 2017 | Feb 3, 2017 | $150,000fully sold | 1 | $150K | DebtRule 506(b) | Form D ↗ |
| Sep 29, 2015 | Oct 8, 2015 | $410,000of $500K target | 4 | $102K | DebtRule 506(b) | Form D ↗ |
| Total, nine offerings | $72,790,625 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Actuate Therapeutics's Form D filed Mar 6, 2024.
AF
Aaron Fletcher
Director
DS
Daniel Schmitt
President and Chief Executive Officer, director
LJ
Leslie Kreis, Jr.
Director
DZ
Dan Zabrowski
Director
TT
Todd Thomson
Director
Earlier filings also listed Pascal Krotee (director, last listed Dec 2020), Alex Andrianopoulos (director, last listed Dec 2020) and Neil Bajpayee (director, last listed Nov 2019).